Ibrutinib-MPEA manufacturers
- Ibrutinib-MPEA
-
- $1980.00
-
2026-07-27
- CAS:1710768-30-1
- Purity:
- Supply Ability: 10g
- Ibrutinib-MPEA
-
- $1980.00
-
2026-07-27
- CAS:1710768-30-1
- Purity:
- Supply Ability: 10g
- Ibrutinib-MPEA
-
- $1980.00
-
2025-07-30
- CAS:1710768-30-1
- Purity:
- Supply Ability: 10g
|
| | Ibrutinib-MPEA Basic information |
| Product Name: | Ibrutinib-MPEA | | Synonyms: | IBRUTINIB-MPEA;IbrutinibMPEA,Ibrutinib MPEA;2-Buten-1-one, 4-[4-(2-aminoethyl)-1-piperazinyl]-1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-, (2E)-;Avadentinib (derivative);(R,E)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-4-(4-(2-aminoethyl)piperazin-1-yl)but-2-en-1-one | | CAS: | 1710768-30-1 | | MF: | C32H39N9O2 | | MW: | 581.71 | | EINECS: | | | Product Categories: | | | Mol File: | 1710768-30-1.mol |  |
| | Ibrutinib-MPEA Chemical Properties |
| Boiling point | 838.4±65.0 °C(Predicted) | | density | 1.35±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | form | Solid | | pka | 10.11±0.10(Predicted) | | color | White to yellow |
| | Ibrutinib-MPEA Usage And Synthesis |
| Uses | Ibrutinib-MPEA (Compound 20) is ibrutinib derivative. Ibrutinib is a covalent and irreversible inhibitor of Bruton's tyrosine kinase (BTK) that has been used to treat haematological malignancies[1]. | | References | [1] Liu N, et al. Direct and two-step bioorthogonal probes for Bruton's tyrosine kinase based on ibrutinib: a comparative study. Org Biomol Chem. 2015 May 14;13(18):5147-57. DOI:10.1039/c5ob00474h |
| | Ibrutinib-MPEA Preparation Products And Raw materials |
|